Prolonged Tp-e interval and Tp-e/QT correlates well with modified Rodnan skin severity score in patients with systemic sclerosis by Okutucu, Sercan et al.
Address for correspondence: Sercan Okutucu, MD, Memorial Ankara Hospital, Department of Cardiology, Cankaya, Ankara, 
P.O: 06520, Turkey, tel: +90 312 2536666 (ext. 4207), fax: +90 312 2536623, e-mail: sercanokutucu@yahoo.com
Received: 17.01.2016 Accepted: 07.05.2016
clinical cardiology
Cardiology Journal 
2016, Vol. 23, No. 3, 242–249
DOI: 10.5603/CJ.a2016.0021
Copyright © 2016 Via Medica
ISSN 1897–5593
242 www.cardiologyjournal.org
ORIGINAL ARTICLE
Prolonged Tp-e interval and Tp-e/QT correlates 
well with modified Rodnan skin severity score  
in patients with systemic sclerosis
Sercan Okutucu1, Ugur Nadir Karakulak2, Hakan Aksoy1, Cengiz Sabanoglu3,  
Vedat Hekimsoy4, Levent Sahiner4, Ergun Baris Kaya4, Ali Akdogan4,  
Giray Kabakci4, Kudret Aytemir4, Lale Tokgozoglu4, Ali Oto1
1Department of Cardiology, Memorial Ankara Hospital, Ankara, Turkey 
2Department of Cardiology, Occupational Diseases Hospital, Ankara Turkey 
3Department of Cardiology, Kirikkale High Speciality Hospital, Kirikkale, Turkey 
4Department of Cardiology, Hacettepe University Faculty of Medicine, Ankara, Turkey
Abstract
Background: Ventricular arrhythmias can be seen in systemic sclerosis (SSc) patients and 
are thought to be a result of fibrosis or ischemia of the ventricular myocardium. Tp-e interval 
and Tp-e/QT ratio are electrocardiographic (ECG) indices to predict ventricular tachyarrhyth-
mia and cardiovascular mortality. We aimed to evaluate Tp-e interval and Tp-e/QT ratio in 
patients with SSc.
Methods: A total of 107 patients with SSc (mean age, 48.6 ± 14.0 years; 96 females) and 100 
healthy controls (mean age, 49.4 ± 8.6 years; 90 females) were enrolled. The standard 12-lead 
ECG was recorded; QTc, Tp-e interval and Tp-e/QT ratio were measured. Modified Rodnan 
skin severity score (MR-SSS) calculated for all SSc patients.
Results: Tp-e interval (90.7 ± 23.8 ms vs. 84.0 ± 20.6 ms, p = 0.032) and Tp-e/QT ratio 
(0.20 ± 0.05 vs. 0.18 ± 0.04, p = 0.007, respectively) were significantly prolonged in SSc 
patients than in the control group. Pearson’s correlation analyses revealed positive correlations 
of MR-SSS with QTc (r = 0.427, p = 0.001), Tp-e interval (r = 0.620, p = 0.001) and Tp-e/ 
/QT ratio (r = 0.615, p = 0.001). MR-SSS (b = 2.108, p = 0.001) and CRP (b = 2.273,  
p = 0.027) were found to be significant independent predictors of Tp-e interval. Similarly, 
MR-SSS (b = 0.004, p = 0.001) was only a significant independent predictor of Tp-e/QT ratio 
among patients with SSc.
Conclusions: The patients with SSc had a prolonged Tp-e interval and Tp-e/QT ratio com-
pared with normal subjects. Furthermore, this prolongation was well correlated with clinical 
severity score among patients with SSc. Ventricular repolarization dispersion as a predictor 
of ventricular arrhythmias was found to be diminished in patients with SSc. Patients with 
SSc, particularly with higher MR-SSS, should be followed closely for adverse cardiovascular 
outcomes. (Cardiol J 2016; 23, 3: 242–249)
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Introduction
Systemic sclerosis (SSc) is a systemic, inflam-
matory and autoimmune disease characterized by 
dysfunction of the endothelium, dysregulation of 
fibroblasts resulting in excessive production of col-
lagen, and abnormalities of the immune system [1]. 
Even if presenting in a limited or diffuse form, 
progressive fibrotic process which is a pathologic 
feature of the disease, tends to involve the skin and 
multiple organ systems such as the gastrointestinal 
tract, kidneys and lungs [2]. The heart is also one 
of the major organs involved in SSc and the pres-
ence of cardiac involvement generally foreshadows 
poor prognosis. Cardiac involvement may be in the 
form of myositis, cardiac failure, cardiac fibrosis, 
coronary artery disease, conduction system abnor-
malities, and pericardial disease [3]. Depending on 
the degree of involvement, increased frequency 
of ventricular ectopic beats, as well as episodes of 
ventricular tachycardia can be seen in SSc patients 
and are thought to be a result of fibrosis or ischemia 
of the ventricular myocardium [4, 5].
Amplification of dispersion of ventricular repo-
larization has long been known as a substrate for 
ventricular arrhythmias and it has been evaluated 
by various methods, such as QT dispersion [6]. 
Recent studies indicate that Tp-e interval, which 
is the interval between the peak and end of the 
T wave on an electrocardiogram (ECG), can be used 
as an index of total (transmural, apico-basal and/or 
global) dispersion of repolarization [7]. Besides, in-
creased Tp-e interval may also be a useful index to 
predict ventricular tachyarrhythmia and cardiovas-
cular mortality [8, 9]. Similarly, abnormally long or 
short QT interval is characterized by an increased 
propensity to develop ventricular tachycardia and 
sudden cardiac death [10, 11]. However, the Tp-e 
and QT intervals might be affected by variations 
of body mass index (BMI) and heart rate (HR) 
[12]. Recently a new index, the Tp-e/QT ratio, has 
been suggested to be a more accurate measure of 
dispersion of ventricular repolarization compared 
to QT and Tp-e intervals, and to be independent 
of alterations in HR [12, 13].
Although ventricular repolarization was pre-
viously evaluated using QT dynamicity and heart 
rate variability (HRV) in patients with SSc [14], 
the novel repolarization indices Tp-e interval and 
Tp-e/QT ratio have not been studied in SSc pa-
tients before. Therefore, the present study aimed 
to evaluate repolarization dispersion by using 
Tp-e interval and Tp-e/QT ratio in patients with 
systemic sclerosis.
Methods
Study population
A total of 149 patients with SSc who fulfilled the 
American College of Rheumatology criteria [15] for 
diagnosis of SSc and presented to the outpatient clinic 
of cardiology and rheumatology departments, were 
enrolled in this study. All subjects had a complete 
history and physical examination. Basic demographic 
characteristics including age, gender, BMI, systolic 
and diastolic blood pressure (BP) and HR of the whole 
population were recorded. Patients with SSc were 
screened in terms of disease duration (defined as 
interval between date of diagnosis and inclusion into 
study), and presence of digital ulcer [16], Raynaud’s 
phenomenon [17] and severity of skin involvement 
in SSc patients were determined by the modified 
Rodnan method and modified Rodnan skin severity 
score (MR-SSS) calculated for all SSc patients. At 
more detailed method description for MR-SSS can 
be found in a study reported by Czirjak et al. [18].
Patients with diabetes mellitus, hypertension, 
dyslipidemia, chronic renal failure, chronic liver 
disease, neurologic diseases, known coronary 
artery or structural heart disease, pulmonary 
hypertension, rhythm abnormalities, use of drugs 
having effects on cardiac repolarization such as 
antiarrhythmic medications and smokers were ex-
cluded from the study. Patients with bundle branch 
block, atrioventricular conduction abnormalities on 
ECG and ECGs without clearly analyzable QT and 
Tp-e intervals were also excluded. After taking into 
account these exclusion criteria, a total of 107 SSc 
patients were found suitable and included in our 
study. During the enrollment process, 3 patients 
with pulmonary hypertension, 2 patients with 
neurological diseases and 2 patients with coronary 
artery disease were excluded. A total of 100 vol-
unteers matched for age and sex with no previous 
history of cardiac disease served as the control 
group. All patients were in New York Heart Asso-
ciation (NYHA) class I. Complete blood count and 
biochemical markers in whole population were ana-
lyzed. Further, all patients were screened for the 
following immunological markers: anti-nuclear an-
tibodies (ANA), anti-centromere antibodies (ACA), 
anti-cardiolipin IgG and IgM, anti-phospholipid IgG 
and IgM, anti-extractable nuclear antigen antibod-
ies complex (ENA, SSA/Ro, SSB/La, Smith [Sm], 
ribonucleoprotein [RNP]), anti-topoisomerase I 
(anti-Scl-70), anti-Jo-1 and anti-double stranded 
DNA (anti-ds-DNA) antibodies.
The study was approved by the local ethics com-
mittee, and patients gave informed written consent.
Figure 1. Measurements of Tp-e interval and the Tp-e/QT ratio. Please note the marked difference between a patient 
with systemic sclerosis and the control group.
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Transthoracic echocardiography
All patients underwent transthoracic echo-
cardiography. Echocardiographic examination 
was performed in the left lateral position from 
parasternal long- and short-axes, and apical 2- and 
4-chamber views. From the parasternal long axis, 
the left ventricular (LV) end-diastolic diameter and 
the LV end-systolic diameter were measured using 
M-mode (at the mitral chordal level perpendicular 
to the long axis of the ventricle). Left ventricular 
ejection fraction was calculated from apical 4-cham-
ber view, according to the modified Simpson’s rule 
[19]. The measurements were based on the criteria 
proposed by the American Society of Echocardi-
ography [20]. In addition, left atrial diameter in 
parasternal long axis view and right ventricular 
end-diastolic diameter in apical 4-chamber view 
were also calculated. Pulmonary systolic arterial 
pressure was estimated by continuous wave (CW) 
Doppler as peak tricuspid regurgitation gradient 
plus an assumed right atrial pressure in relation to 
the size and respiratory variation of inferior vena 
cava visualized in subcostal view [19]. Measure-
ments of mitral inflow included the peak early filling 
(E-wave) and late diastolic filling (A-wave) veloci-
ties, deceleration time of early filling velocity, and 
the isovolumic relaxation time, derived by placing 
the cursor of the CW Doppler in the LV outflow 
tract to simultaneously display the end of aortic 
ejection and the onset of mitral inflow. Pericardial 
effusion was determined by echocardiography and 
recorded if present.
Electrocardiogram and measurement  
of indices
The 12-lead ECG was recorded at a paper 
speed of 50 mm/s (Nihon Kohden, Tokyo, Japan) at 
rest in the supine position. An “appropriate” ECG 
was defined as at least 10 analyzable leads for the 
required measurements. Otherwise, the ECG was 
considered noisy. Resting HR was measured from the 
ECG taken during the patient evaluation. ECG meas-
urements of QT and Tp-e intervals were performed 
by a cardiologist who was blinded to the patient data 
and verified by a second physician to avoid error in 
measurements. An average value of 3 readings was 
calculated for each lead. The QT interval was meas-
ured from the onset of the QRS complex to the point 
at which the tangent of the maximal downslope of the 
descending limb of the T wave crossed the isoelectric 
baseline and was corrected for HR using the Bazett’s 
formula: QTc = QT / √ R – R interval [21]. The Tp-e 
interval was defined as the interval from the peak of 
T wave to the end of T wave. Measurements of Tp-e 
interval were performed from precordial leads [22]. 
Finally, the Tp-e/QT ratio was calculated from these 
measurements (Fig. 1).
All ECG measurements were performed by 
2 independent cardiologists who were blinded to 
other patient information (mean of 2 measurements 
were used for analysis). Intra-observer agreement 
for QT and Tpe measurements was substantial (for 
QT measurement, simple agreement was 96% and 
Kappa (K): 0.86–0.95, p = 0.001; for Tp-e measure-
ment, simple agreement was 94% and K: 0.84–0.93, 
p = 0.001). Similarly, inter-observer agreement 
was also satisfactory (for QT measurement, simple 
agreement was 94%, K: 0.84–0.88, p = 0.001; for 
Tp-e measurement, simple agreement was 92%, 
K: 0.70–0.82, p = 0.001).
Statistical analyses
Statistical analyses were performed using 
SPSS for Windows 20 (SPSS Inc., Chicago, IL, 
USA). Numerical variables with a normal distribu-
tion were presented as mean ± standard deviation, 
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numerical variables with a skewed distribution 
were presented as median [minimum and maxi-
mum] and categorical variables were presented as 
percentages. For numerical variables, an indepen-
dent sample t-test and Mann-Whitney U test were 
used for inter-group comparisons. Pearson c2 test 
was used to compare categorical variables. Pear-
son correlation analysis was used to test normal 
variables, while Spearman correlation analysis was 
used for variables not showing normal distribution. 
Multiple linear regression analysis was used to 
determine possible predictors among risk factors. 
P < 0.05 was considered statistically significant.
Results
General characteristics of study population
Baseline demographic characteristics and 
echocardiographic parameters were similar be-
tween the two groups. These parameters are 
shown in Table 1. Pericardial effusion was seen in 
none of the controls, while mild pericardial effu-
sion (< 10 mm) was seen in 23.4% (n = 25) of the 
SSc patients. The median disease duration was 
76 months (minimum 1 month, maximum 480 months) 
in the SSc group. Complete blood count and bio-
chemistry values of the two groups are shown in 
Table 2. There were no statistically significant 
differences between the groups in terms of these 
laboratory parameters. A digital ulcer was present 
in 54.2% (n = 58) and Raynaud’s phenomenon was 
present in 50.5% (n = 54) of SSc patients. The 
main clinical and serological data of SSc patients 
are represented in Table 3.
Electrocardiographic indices
Tp-e interval (90.7 ± 23.8 ms vs. 84.0 ± 20.6 ms, 
p = 0.032, respectively) and Tp-e/QT ratio (0.20 ± 
± 0.05 vs. 0.18 ± 0.04, p = 0.007, respectively) 
were significantly higher in SSc patients when 
compared to those of the control group. However, 
QTc interval (422 ± 24 ms vs. 426 ± 31 ms, p = 
= 0.365) was found to be similar in SSc patients 
with respect to the control group (Fig. 2).
Effects of all independent variables on Tp-e in-
terval were examined separately in a univariate lin-
ear regression analysis. Erythrocyte sedimentation 
rate (ESR) (p = 0.001, b = 0.576), C-reactive protein 
(CRP; p = 0.001, b = 4.075), and MR-SSS (p = 0.001, 
b = 2.373) were found to be significant predictors 
of Tp-e interval. These significant variables were 
further analyzed in a multivariate linear regression 
model. MR-SSS (b = 2.108, 95% CI 1.528–2.688, 
p = 0.001) and CRP (b = 2.273, 95% CI 0.258–
–4.287, p = 0.027) were found to be significant 
independent predictors of Tp-e interval.
Table 1. Baseline demographic characteristics and echocardiographic parameters of the two groups.
Variable Systemic sclerosis group (n = 107) Control group (n = 100) P
Age [years] 48.6 ± 14.0 49.4 ± 8.6 0.613
Gender (female/male) 96/11 90/10 0.947
Basal heart rate [min] 72.1 ± 11.1 73.0 ± 9.8 0.547
Body mass index [kg/m2] 22.3 ± 4.3 23.1 ± 5.4 0.238
Systolic BP [mm Hg] 120.7 ± 12.7 118.3 ± 11.5 0.162
Diastolic BP [mm Hg] 71.4 ± 7.9 70.5 ± 7.9 0.403
LV end-diastolic diameter [cm] 4.53 ± 0.32 4.60 ± 0.28 0.102
LV end-systolic diameter [cm] 2.86 ± 0.29 2.79 ± 0.29 0.096
LVEF [%] 64.1 ± 3.5 64.7 ± 2.7 0.167
Left atrial dimension [cm] 3.29 ± 0.35 3.36 ± 0.35 0.134
RV end-diastolic diameter [cm] 2.56 ± 0.21 2.53 ± 0.24 0.368
Systolic PAP [mm Hg] 27.5 ± 4.9 26.3 ± 5.5 0.098
E wave [cm/s] 79.6 ± 14.9 82.5 ± 15.4 0.170
A wave [cm/s] 57.1 ± 15.3 54.4 ± 14.9 0.200
Deceleration time [ms] 176.7 ± 42.3 183.0 ± 45.7 0.304
Isovolumic relaxation time [ms] 91.8 ± 13.7 88.5 ± 14.8 0.097
MR-SSS 19.2 ± 6.2 NA
Numerical variables with a normal distribution were presented as mean ± standard deviation and those without a normal distribution were 
presented as median [minimum – maximum]; BP — blood pressure; LV — left ventricle; LVEF — left ventricular ejection fraction; RV — right 
ventricle; PAP — pulmonary arterial pressure; MR-SSS — modified Rodnan skin sclerosis score
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(p = 0.001, b = 0.001), CRP (p = 0.001, b = 0.008), 
and MR-SSS (p = 0.001, b = 0.005) were found to 
be significant predictors of Tp-e/QT ratio. These 
significant variables were further analyzed in multi-
variate linear regression model. MR-SSS (b = 0.004, 
95% CI 0.003–0.003, p = 0.001) was found to be 
only significant independent predictors of Tp-e/QT 
ratio among patients with SSc.
Pearson’s correlation analyses revealed posi-
tive correlations of MR-SSS with QTc (r = 0.427, 
p = 0.001), Tp-e interval (r = 0.620, p = 0.001) 
and Tp-e/QT ratio (r = 0.615, p = 0.001) (Fig. 3). 
There were also weak positive correlations of ESR 
with Tp-e interval (r = 0.328, p = 0.001) and Tp-e/ 
/QT ratio (r = 0.308, p = 0.001).
Discussion
The main findings of the present study are 
as follows: (1) repolarization dispersion assessed 
by using Tp-e interval and Tp-e/QT ratio was 
prolonged in patients with SSc when compared to 
that of the controls, (2) this prolongation was well 
correlated with MR-SSS, (3) MR-SSS was found to 
be an independent predictor of both Tp-e interval 
and Tp-e/QT ratio.
To the best of our knowledge, this is the first 
study to report on Tp-e interval and Tp-e/QT ratio 
in SSc patients. The Tp-e/QT ratio is a relatively 
new index of increased dispersion of ventricular 
repolarization and is considered to be a more sensi-
tive index of arrhythmogenesis compared to sole 
use of either Tp-e or QT intervals [12]. Therefore, 
Table 3. Main clinical and serologic data of  
systemic sclerosis patients.
Variable N (%)
Digital ulcer positivity 58 (54.2%)
Raynaud’s phenomenon positivity 54 (50.5%)
Anti-nuclear antibodies positivity 82 (76.6%)
Anti-double stranded DNA antibodies  
positivity
10 (9.3%)
Anti-centromere antibodies positivity 8 (7.5%)
Anti-extractable nuclear antigen  
antibodies positivity
61 (57.0%)
Anti-topoisomerase I (anti-Scl-70)  
antibodies positivity
48 (44.9%)
Anti SSA/Ro antibodies positivity 8 (7.5%)
Anti SSB/La antibodies positivity 0 (0%)
Anti Smith (Sm) antibodies positivity 1 (0.9%)
Anti ribonucleoprotein (RNP)  
antibodies positivity
12 (11.2%)
Anti-Jo-1 antibodies positivity 0 (0%)
Anti-cardiolipin IgM antibodies  
positivity
4 (3.7%)
Anti-cardiolipin IgG antibodies  
positivity
5 (4.7%)
Anti-phospholipid IgM antibodies  
positivity
1 (0.9%)
Anti-phospholipid IgG antibodies  
positivity
2 (1.9%)
Table 2. Complete blood count and biochemistry values of the two groups.
Variable Systemic sclerosis group (n = 107) Control group (n = 100) P
Hemoglobin [g/dL] 12.4 ± 1.4 12.7 ± 2.0 0.210
White blood cell count [/µL] 6700 [5100–10000] 6350 [3000–12000] 0.233
Platelet count [/µL] 251000 ± 99000 236000 ± 87000 0.249
Creatinine [mg/dL] 0.74 ± 0.17 0.79 ± 0.22 0.067
Blood urea nitrogen [mg/dL] 17.1 ± 4.1 16.5 ± 3.4 0.254
LDL-cholesterol [mg/dL] 119.4 ± 41.4 115.6 ± 42.7 0.516
HDL-cholesterol [mg/dL] 43.5 ± 11.2 41.6 ± 9.8 0.196
Triglyceride [mg/dL] 190.3 ± 58.8 185.6 ± 60.1 0.570
Erythrocyte sedimentation rate [mm/h] 16 [2–90] 15 [2–56] 0.035
C-reactive protein [mg/dL] 0.5 [0.01–14.6] 0.4 [0.01–4.7] 0.056
Procalcitonin [ng/mL] 1.1 [0.01–9.0] 1.0 [0.03–5] 0.239
Alanine aminotransferase [U/L] 22.3 ± 6.7 24.1 ± 8.6 0.093
Aspartate aminotransferase [U/L] 29.5 ± 9.6 28.1 ± 9.1 0.283
Numerical variables with normal distribution were presented as the mean ± standard deviation and those without normal distribution were 
presented as median [minimum – maximum]; LDL — low density lipoprotein; HDL — high density lipoprotein cholesterol
Similarly, influence of all independent vari-
ables on Tp-e/QT ratio was examined separately 
in a univariate linear regression analysis. ESR 
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this ratio is being used increasingly more frequent-
ly as an electrocardiographic index of ventricular 
arrhythmogenesis in various diseases. Previous 
studies have shown that prolongation of the Tp-e 
interval is associated with increased mortality in 
Brugada syndrome, hypertrophic cardiomyopathy, 
and in patients undergoing primary percutaneous 
coronary intervention for myocardial infarction 
[13, 22, 23]. Yamaguchi et al. [24] found that the 
Tp-e/QT ratio is a superior predictor of torsades de 
pointes than either QTc interval or QTd in patients 
with long QT syndrome (LQTS). Likewise, QTc did 
not reach statistical significance between the two 
groups in our study. However, Tp-e interval and 
Tp-e/QT ratio were prolonged in patients with SSc 
when compared to that of the controls.
Many studies have evaluated abnormalities of the 
ventricular myocardium and arrhythmias and markers 
of such arrhythmias in patients with SSc. It has been 
found that SSc patients show tendency to tachycardia 
and have significantly lower heart rate turbulence 
values compared to controls [25, 26]. Similarly, Çiftçi 
et al. [14], using 24-h ambulatory ECG recording, 
found that diffuse SSc is associated with a significant 
worsening of HRV and QT dynamicity parameters. 
In another study, Paradiso et al. [27], using signal 
averaged ECG, found that nearly half of SSc patients 
have late ventricular potentials. Additionally, Sgrec-
cia et al. [28] reported that patients with SSc have 
increased QTc interval, QTd, and QTc dispersion.
Various mechanisms have been proposed for 
heterogeneity in ventricular repolarization and 
Figure 3. Correlation of Modified Rodnan skin severity score with (A) QTc, (B) Tp-e interval and (C) Tp-e/QT ratio; 
r indicates correlation coefficient.
Figure 2. QTc (A), Tp-e interval (B) and Tp-e/QT ratio (C) in patients with systemic sclerosis (SSc) and the control 
group.
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abnormalities in markers of arrhythmogenesis in 
patients with SSc. The first possible mechanism 
is inflammation and fibrosis of cardiac tissues. 
Autoimmunity, vasculopathy and fibrosis, which are 
the basic components of pathophysiology in SSc, 
affect the heart just as they affect all organ systems [3]. 
Cardiac vascular involvement in SSc is usually 
seen in small arterial segments and exercise-
induced perfusion defects despite normal coronary 
angiogram are thought to be related to vasospasm 
and abnormal resistance to flow at the level of the 
microcirculation or myocardial interstitium [29]. 
Fibrotic process can occur directly due to inflam-
matory and autoimmune mechanisms and it may 
also be ischemia-mediated as a result of abnormal-
ity in microcirculation [5]. This fibrotic process 
that is seen in SSc tends to be patchy [30, 31]. 
In addition, it is well recognized that ventricular 
myocardium is electrically a heterogeneous struc-
ture [32]. The cells located in the subendocardial 
layer have the longest action potential duration 
followed by endocardial and epicardial cells [12]. 
Therefore, transmural dispersion caused by this 
voltage gradient between layers may be damaged 
by a fibrotic process similar to that in SSc. In our 
study, supporting data above, higher Tp-e interval 
and Tp-e/QT ratio was well correlated with MR- 
-SSS, and MR-SSS was found to be an independent 
predictor of both Tp-e interval and Tp-e/QT ratio.
The second possible mechanism is dysregu-
lation of the autonomic nervous system. Vaseghi 
et al. [33] found that sympathetic stimulation 
increases Tp-e interval and thus myocardial dis-
persion of repolarization. Additionally, Tanabe 
et al. [34] showed that sympathetic stimulation 
produces a greater increase in both transmural and 
spatial dispersion of repolarization in patients with 
LQTS. In light of these studies, similar autonomic 
dysregulation which could be seen in SSc may in-
crease dispersion of repolarization and predispose 
to ventricular arrhythmias [35].
In the present study, there were weak signifi-
cant positive correlations of Tp-e interval and Tp-e/ 
/QT ratio with ESR. Furthermore, CRP was found 
to be another independent predictor of Tp-e inter-
val. Inflammation is known to play an essential role 
in the pathogenesis of cardiovascular diseases such 
as coronary artery disease and arrhythmias [36]. 
This finding supports the above-mentioned effect 
of inflammatory mechanisms on the ventricular 
myocardium and thus, supports the tendency of 
arrhythmia seen in an inflammatory disease, such 
as SSc. This relationship between inflammatory 
activity and Tp-e interval and Tp-e/QT ratio is 
similar to the result of studies performed on 
patients with rheumatic arthritis and ankylosing 
spondylitis [37, 38].
Our results may contribute to the pathophysio-
logical mechanisms of increased prevalence of ven-
tricular arrhythmias and increased cardiovascular 
mortality risk by indicating increased ventricular 
repolarization heterogeneity and increased inflam-
mation in these patients. The increased frequency 
of ventricular arrhythmias and sudden cardiac 
death might be explained by prolonged transmural 
dispersion and chronic ongoing systemic inflamma-
tion in SSc patients. Therefore, our findings may 
be a reference for further studies.
Limitations of the study
The major limitation of our study is its cross-
sectional design and lack of follow-up of the pa-
tients. The number of patients included is very 
small and since we did not assess the association 
between ventricular arrhythmias with Tp-e interval 
and Tp-e/QT ratio, there is no information regard-
ing any cardiovascular endpoints. Therefore, we 
could not evaluate the potential prognostic role of 
the electrocardiographic ventricular repolarization 
indices with respect to future events. In regards 
to patients included in study, organ complications 
might preclude participation. Therefore, study 
population might be skewed to the early phases of 
the disease. Additionally, since a very limited group 
of patients were included due to several exclusion 
criteria, and since no distinction was made between 
limited/diffuse SSc, the results of this study cannot 
be generalized to the whole SSc patient population. 
For this reason, long-term follow-up and large-scale 
prospective studies are needed to determine the 
predictive value of prolonged Tp-e interval and 
increased Tp-e/QT ratio, and to understand the 
pathophysiology, as well as to make accurate clini-
cal decisions in this population.
Conclusions
Our study pointed out that Tp-e interval and 
Tp-e/QT ratio were increased in SSc patients. Our 
results also showed that these electrocardiographic 
indices of ventricular repolarization were sig-
nificantly correlated with MR-SSS. Furthermore, 
MR-SSS was found to be a significant independ-
ent predictor of Tp-e interval and Tp-e/QT ratio 
among patients with SSc. When the prognostic 
significance of Tp-e interval and Tp-e/QT ratio is 
considered, patients with SSc, particularly with 
higher MR-SSS, should be followed closely for 
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adverse cardiovascular outcomes. Further stud-
ies are required to understand the pathogenesis 
and consequences of repolarization dispersion and 
ventricular arrhythmias in systemic sclerosis.
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